Barroso, E. B. C. (2026) “Dual anti-human epidermal growth factor receptortype 2 blockade with taxane as first-line treatment for HER2-positive breast cancer with visceral metastases: a technology incorporation assessment within the Brazilian Unified Health System”, Mastology. Rio de Janeiro, 35(suppl.1). doi: 10.29289/259453942025V35S1055.